Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Talking Pill App Targets Adherence, Counterfeit Avoidance

By Pharmaceutical Processing | August 19, 2015

TruMedicines launched a Kickstarter campaign today for its phone app designed to ensure the safety of medications. The app uses a secure, accurate and immediate two step authentication process via QR code and cloud-based image recognition to confirm medications are genuine and safe. Verification of authenticity includes details about where the drug was made, the expiration date and adverse reactions. The app provides the information both verbally and in large font in 52 languages.

Additional features offer incentives for adherence. Launching today, the 40 day TruMedicines Kickstarter campaign seeks to secure $150,000 in funding in anticipation of an April 2016 launch. Full details about the campaign and the issues surrounding medication adherence and counterfeit drugs can be found at https://www.kickstarter.com/projects/1679318871/1651811011?token=7b90c3f2.

In 2010, The National Association of Boards of Pharmacy found that of the nearly 11,000 internet pharmacies in business, a staggering 97% were selling counterfeit drugs.

“When I learned about the epidemic of children dying due to counterfeit malaria pills, it became my mission to find a solution,” stated TruMedicines founder and author of the book Making Pills Talk, David Prokop. “It also assists patients with compliance to ensure that medications are taken as prescribed.”

The TruMedicines app is tackling the issue of adherence to medical prescriptions via notifications and patient rewards. SMS text notifications will alert family and doctors if a patient skips a dose and a ‘gamification’ rewards program is activated when medications are scanned – incentivizing adherence. The World Health Organization notes a lack of medication compliance can lead to both reduced health benefits and increased expenses. Reports indicated that for chronic illnesses, 90 percent of diabetes patients to 50 percent of cancer patients do not fully comply with their medicine therapies.

Related Articles Read More >

Sandoz Logo 2025
Sandoz breaks ground on biosimilar plant in Slovenia
Nymi Logo_2022 (1)
Nymi, Caliber partner on passwordless authentication for pharma manufacturing
Building a resilient pharma supply chain
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE